Blood and Marrow Transplant Program
Cedars-Sinai Blood and Marrow Transplant Program, one of the largest in the Los Angeles region, has completed more than 1,500 stem cell and bone marrow transplant procedures since it was established two decades ago and now performs about 140 transplants a year, including 100 autologous transplants for patients with leukemia and lymphoma. Blood and marrow transplants are commonly used to treat:
- Acute and chronic leukemia
- Hodgkin’s disease
- Non-Hodgkin’s lymphoma
- Multiple myeloma
The Blood and Marrow Transplant Program performs autologous, allogeneic- related and unrelated, and allogeneic cord blood transplants, using HEPA-filtered, positive-pressure rooms to ensure the safety and comfort of patients. The program is one of only two in the country offering bloodless bone marrow transplant to Jehovah’s Witnesses with lymphoma, multiple myeloma and other blood cancers.
The Blood and Marrow Transplant program is accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) and the National Marrow Donor Program (NMDP). Drawn by our reputation for quality care, patients come from all over Southern California, as well as neighboring states, to take full advantage of the specialized, first-hand experience of our dedicated doctors. Our team approach to care involves oncologists from many different specialties as well as oncology and case management nurses, transfusion medicine specialists, pharmacists, dieticians, psychologists, social workers, and occupational and physical therapists. Comprehensive services encompass diagnosis, screening, pre-transplant preparation, education, post-discharge care, recovery and dietary counseling. The Cedars-Sinai HLA (Human Leukocyte Antigen) Typing Lab ranks in the top 10 percent of HLA donor/recipient cross-matching facilities worldwide.
For patients facing the challenge of a variety of cancerous diseases, stem cell blood and bone marrow transplants offer possibility of a cure or control of their disease for patients who risk recurrence or who have not responded to traditional therapy or who may have suffered a relapse.
In the 2012-13 U.S. News and World Report Best Hospitals issue, Cedars-Sinai once again ranked among America's best in Cancer.
